Marinus Pharmaceuticals Inc (MRNS)
1.33
+0.03
(+2.31%)
USD |
NASDAQ |
May 17, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Debt to Equity Ratio: -4.471 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | -4.471 |
December 31, 2023 | 4.353 |
September 30, 2023 | 1.329 |
June 30, 2023 | 1.255 |
March 31, 2023 | 0.8558 |
December 31, 2022 | 0.6122 |
September 30, 2022 | 0.8631 |
June 30, 2022 | 14.65 |
Date | Value |
---|---|
March 31, 2022 | 1.731 |
December 31, 2021 | 0.763 |
September 30, 2021 | 0.517 |
June 30, 2021 | 0.1154 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.471
Minimum
Mar 2024
14.65
Maximum
Jun 2022
1.505
Average
0.763
Median
Dec 2021
Debt to Equity Ratio Benchmarks
Pfizer Inc | 0.7445 |
ACADIA Pharmaceuticals Inc | 0.00 |
Alnylam Pharmaceuticals Inc | -4.660 |
Regeneron Pharmaceuticals Inc | 0.0735 |
Actinium Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 137.35M |
Total Liabilities (Quarterly) | 153.78M |
Shareholders Equity (Quarterly) | -16.43M |
Current Ratio | 3.070 |
Net Debt Paydown Yield | -0.10% |